Back Mller, MU, Preker, A (4 Jan 2024) 'Interview with weight loss drugs inventor Lotte Bjerre Knudsen', Spiegel International
We are looking at very specific metabolic markers
The GLP-1 receptor agonists cardiovascular benefits are believed to stem from their effects in reducing dysfunctional body fat cells, improving glycemic control, reducing blood pressure and inflammation, and perhaps improving vascular endothelial function and plaque stability
Still, nearly half of people who are currently taking GLP-1s said they intend to stay on the drugs permanently
95% CI 0.80-0.82)
Providing a diverse range of dietary supplement products across multiple dosage forms allows supplement distributors to cater to regional consumer preferences , accelerate adoption, and meet the growing global demand for weight management and gut health solutions